Global Dermatophytic Onychomycosis Treatment Market Size, Status and Forecast 2024-2031

Report ID: 1013317 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Systemic Therapy
        1.2.3 Topical Therapy
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Dermatophytic Onychomycosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Dermatology Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Dermatophytic Onychomycosis Treatment Market Perspective (2016-2027)
    2.2 Dermatophytic Onychomycosis Treatment Growth Trends by Regions
        2.2.1 Dermatophytic Onychomycosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Dermatophytic Onychomycosis Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Dermatophytic Onychomycosis Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Dermatophytic Onychomycosis Treatment Industry Dynamic
        2.3.1 Dermatophytic Onychomycosis Treatment Market Trends
        2.3.2 Dermatophytic Onychomycosis Treatment Market Drivers
        2.3.3 Dermatophytic Onychomycosis Treatment Market Challenges
        2.3.4 Dermatophytic Onychomycosis Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Dermatophytic Onychomycosis Treatment Players by Revenue
        3.1.1 Global Top Dermatophytic Onychomycosis Treatment Players by Revenue (2016-2021)
        3.1.2 Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Dermatophytic Onychomycosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Dermatophytic Onychomycosis Treatment Revenue
    3.4 Global Dermatophytic Onychomycosis Treatment Market Concentration Ratio
        3.4.1 Global Dermatophytic Onychomycosis Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Dermatophytic Onychomycosis Treatment Revenue in 2020
    3.5 Dermatophytic Onychomycosis Treatment Key Players Head office and Area Served
    3.6 Key Players Dermatophytic Onychomycosis Treatment Product Solution and Service
    3.7 Date of Enter into Dermatophytic Onychomycosis Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Dermatophytic Onychomycosis Treatment Breakdown Data by Type
    4.1 Global Dermatophytic Onychomycosis Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Type (2022-2027)

5 Dermatophytic Onychomycosis Treatment Breakdown Data by Application
    5.1 Global Dermatophytic Onychomycosis Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Dermatophytic Onychomycosis Treatment Market Size (2016-2027)
    6.2 North America Dermatophytic Onychomycosis Treatment Market Size by Type
        6.2.1 North America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021)
        6.2.2 North America Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027)
        6.2.3 North America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2027)
    6.3 North America Dermatophytic Onychomycosis Treatment Market Size by Application
        6.3.1 North America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021)
        6.3.2 North America Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027)
        6.3.3 North America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2027)
    6.4 North America Dermatophytic Onychomycosis Treatment Market Size by Country
        6.4.1 North America Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021)
        6.4.2 North America Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Dermatophytic Onychomycosis Treatment Market Size (2016-2027)
    7.2 Europe Dermatophytic Onychomycosis Treatment Market Size by Type
        7.2.1 Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2027)
    7.3 Europe Dermatophytic Onychomycosis Treatment Market Size by Application
        7.3.1 Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2027)
    7.4 Europe Dermatophytic Onychomycosis Treatment Market Size by Country
        7.4.1 Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type
        8.2.1 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application
        8.3.1 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region
        8.4.1 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Dermatophytic Onychomycosis Treatment Market Size (2016-2027)
    9.2 Latin America Dermatophytic Onychomycosis Treatment Market Size by Type
        9.2.1 Latin America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2027)
    9.3 Latin America Dermatophytic Onychomycosis Treatment Market Size by Application
        9.3.1 Latin America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2027)
    9.4 Latin America Dermatophytic Onychomycosis Treatment Market Size by Country
        9.4.1 Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type
        10.2.1 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application
        10.3.1 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country
        10.4.1 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Bausch Health Companies
        11.1.1 Bausch Health Companies Company Details
        11.1.2 Bausch Health Companies Business Overview
        11.1.3 Bausch Health Companies Dermatophytic Onychomycosis Treatment Introduction
        11.1.4 Bausch Health Companies Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
        11.1.5 Bausch Health Companies Recent Development
    11.2 Novartis AG
        11.2.1 Novartis AG Company Details
        11.2.2 Novartis AG Business Overview
        11.2.3 Novartis AG Dermatophytic Onychomycosis Treatment Introduction
        11.2.4 Novartis AG Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
        11.2.5 Novartis AG Recent Development
    11.3 Johnson and Johnson
        11.3.1 Johnson and Johnson Company Details
        11.3.2 Johnson and Johnson Business Overview
        11.3.3 Johnson and Johnson Dermatophytic Onychomycosis Treatment Introduction
        11.3.4 Johnson and Johnson Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
        11.3.5 Johnson and Johnson Recent Development
    11.4 Galderma S.A.
        11.4.1 Galderma S.A. Company Details
        11.4.2 Galderma S.A. Business Overview
        11.4.3 Galderma S.A. Dermatophytic Onychomycosis Treatment Introduction
        11.4.4 Galderma S.A. Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
        11.4.5 Galderma S.A. Recent Development
    11.5 Celtic Pharmaceuticals
        11.5.1 Celtic Pharmaceuticals Company Details
        11.5.2 Celtic Pharmaceuticals Business Overview
        11.5.3 Celtic Pharmaceuticals Dermatophytic Onychomycosis Treatment Introduction
        11.5.4 Celtic Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
        11.5.5 Celtic Pharmaceuticals Recent Development
    11.6 Anacor Pharmaceuticals
        11.6.1 Anacor Pharmaceuticals Company Details
        11.6.2 Anacor Pharmaceuticals Business Overview
        11.6.3 Anacor Pharmaceuticals Dermatophytic Onychomycosis Treatment Introduction
        11.6.4 Anacor Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
        11.6.5 Anacor Pharmaceuticals Recent Development
    11.7 Moberg Pharma AB
        11.7.1 Moberg Pharma AB Company Details
        11.7.2 Moberg Pharma AB Business Overview
        11.7.3 Moberg Pharma AB Dermatophytic Onychomycosis Treatment Introduction
        11.7.4 Moberg Pharma AB Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
        11.7.5 Moberg Pharma AB Recent Development
    11.8 GlaxoSmithKline
        11.8.1 GlaxoSmithKline Company Details
        11.8.2 GlaxoSmithKline Business Overview
        11.8.3 GlaxoSmithKline Dermatophytic Onychomycosis Treatment Introduction
        11.8.4 GlaxoSmithKline Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
        11.8.5 GlaxoSmithKline Recent Development
    11.9 Pfizer Inc
        11.9.1 Pfizer Inc Company Details
        11.9.2 Pfizer Inc Business Overview
        11.9.3 Pfizer Inc Dermatophytic Onychomycosis Treatment Introduction
        11.9.4 Pfizer Inc Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021)
        11.9.5 Pfizer Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Systemic Therapy
    Table 3. Key Players of Topical Therapy
    Table 4. Key Players of Others
    Table 5. Global Dermatophytic Onychomycosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Dermatophytic Onychomycosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Dermatophytic Onychomycosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Dermatophytic Onychomycosis Treatment Market Share by Regions (2016-2021)
    Table 9. Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Dermatophytic Onychomycosis Treatment Market Share by Regions (2022-2027)
    Table 11. Dermatophytic Onychomycosis Treatment Market Trends
    Table 12. Dermatophytic Onychomycosis Treatment Market Drivers
    Table 13. Dermatophytic Onychomycosis Treatment Market Challenges
    Table 14. Dermatophytic Onychomycosis Treatment Market Restraints
    Table 15. Global Dermatophytic Onychomycosis Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Dermatophytic Onychomycosis Treatment Market Share by Players (2016-2021)
    Table 17. Global Top Dermatophytic Onychomycosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis Treatment as of 2020)
    Table 18. Ranking of Global Top Dermatophytic Onychomycosis Treatment Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Dermatophytic Onychomycosis Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Dermatophytic Onychomycosis Treatment Product Solution and Service
    Table 22. Date of Enter into Dermatophytic Onychomycosis Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Type (2016-2021)
    Table 26. Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Dermatophytic Onychomycosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Application (2016-2021)
    Table 30. Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Bausch Health Companies Company Details
    Table 63. Bausch Health Companies Business Overview
    Table 64. Bausch Health Companies Dermatophytic Onychomycosis Treatment Product
    Table 65. Bausch Health Companies Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
    Table 66. Bausch Health Companies Recent Development
    Table 67. Novartis AG Company Details
    Table 68. Novartis AG Business Overview
    Table 69. Novartis AG Dermatophytic Onychomycosis Treatment Product
    Table 70. Novartis AG Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
    Table 71. Novartis AG Recent Development
    Table 72. Johnson and Johnson Company Details
    Table 73. Johnson and Johnson Business Overview
    Table 74. Johnson and Johnson Dermatophytic Onychomycosis Treatment Product
    Table 75. Johnson and Johnson Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
    Table 76. Johnson and Johnson Recent Development
    Table 77. Galderma S.A. Company Details
    Table 78. Galderma S.A. Business Overview
    Table 79. Galderma S.A. Dermatophytic Onychomycosis Treatment Product
    Table 80. Galderma S.A. Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
    Table 81. Galderma S.A. Recent Development
    Table 82. Celtic Pharmaceuticals Company Details
    Table 83. Celtic Pharmaceuticals Business Overview
    Table 84. Celtic Pharmaceuticals Dermatophytic Onychomycosis Treatment Product
    Table 85. Celtic Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
    Table 86. Celtic Pharmaceuticals Recent Development
    Table 87. Anacor Pharmaceuticals Company Details
    Table 88. Anacor Pharmaceuticals Business Overview
    Table 89. Anacor Pharmaceuticals Dermatophytic Onychomycosis Treatment Product
    Table 90. Anacor Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
    Table 91. Anacor Pharmaceuticals Recent Development
    Table 92. Moberg Pharma AB Company Details
    Table 93. Moberg Pharma AB Business Overview
    Table 94. Moberg Pharma AB Dermatophytic Onychomycosis Treatment Product
    Table 95. Moberg Pharma AB Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
    Table 96. Moberg Pharma AB Recent Development
    Table 97. GlaxoSmithKline Company Details
    Table 98. GlaxoSmithKline Business Overview
    Table 99. GlaxoSmithKline Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
    Table 100. GlaxoSmithKline Recent Development
    Table 101. Pfizer Inc Company Details
    Table 102. Pfizer Inc Business Overview
    Table 103. Pfizer Inc Dermatophytic Onychomycosis Treatment Product
    Table 104. Pfizer Inc Revenue in Dermatophytic Onychomycosis Treatment Business (2016-2021) & (US$ Million)
    Table 105. Pfizer Inc Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Dermatophytic Onychomycosis Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Systemic Therapy Features
    Figure 3. Topical Therapy Features
    Figure 4. Others Features
    Figure 5. Global Dermatophytic Onychomycosis Treatment Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Dermatology Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Dermatophytic Onychomycosis Treatment Report Years Considered
    Figure 10. Global Dermatophytic Onychomycosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Dermatophytic Onychomycosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Dermatophytic Onychomycosis Treatment Market Share by Regions: 2020 VS 2027
    Figure 13. Global Dermatophytic Onychomycosis Treatment Market Share by Regions (2022-2027)
    Figure 14. Global Dermatophytic Onychomycosis Treatment Market Share by Players in 2020
    Figure 15. Global Top Dermatophytic Onychomycosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis Treatment as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Dermatophytic Onychomycosis Treatment Revenue in 2020
    Figure 17. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Type (2016-2021)
    Figure 18. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Type (2022-2027)
    Figure 19. North America Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Dermatophytic Onychomycosis Treatment Market Share by Type (2016-2027)
    Figure 21. North America Dermatophytic Onychomycosis Treatment Market Share by Application (2016-2027)
    Figure 22. North America Dermatophytic Onychomycosis Treatment Market Share by Country (2016-2027)
    Figure 23. United States Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Dermatophytic Onychomycosis Treatment Market Share by Type (2016-2027)
    Figure 27. Europe Dermatophytic Onychomycosis Treatment Market Share by Application (2016-2027)
    Figure 28. Europe Dermatophytic Onychomycosis Treatment Market Share by Country (2016-2027)
    Figure 29. Germany Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Share by Region (2016-2027)
    Figure 39. China Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Dermatophytic Onychomycosis Treatment Market Share by Type (2016-2027)
    Figure 47. Latin America Dermatophytic Onychomycosis Treatment Market Share by Application (2016-2027)
    Figure 48. Latin America Dermatophytic Onychomycosis Treatment Market Share by Country (2016-2027)
    Figure 49. Mexico Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Share by Country (2016-2027)
    Figure 55. Turkey Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Bausch Health Companies Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
    Figure 59. Novartis AG Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
    Figure 60. Johnson and Johnson Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
    Figure 61. Galderma S.A. Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
    Figure 62. Celtic Pharmaceuticals Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
    Figure 63. Anacor Pharmaceuticals Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
    Figure 64. Moberg Pharma AB Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
    Figure 65. GlaxoSmithKline Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
    Figure 66. Pfizer Inc Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bausch Health Companies
Novartis AG
Johnson and Johnson
Galderma S.A.
Celtic Pharmaceuticals
Anacor Pharmaceuticals
Moberg Pharma AB
GlaxoSmithKline
Pfizer Inc
Frequently Asked Questions
Dermatophytic Onychomycosis Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dermatophytic Onychomycosis Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dermatophytic Onychomycosis Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Urethral Stricture

A urethral stricture is a narrowing of the urethra caused by injury, instrumentation, infection a ... Read More